Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s13669-016-0140-8 http://scihub22266oqcxt.onion/10.1007/s13669-016-0140-8 C4762912!4762912!26949570     free     free     free       Curr+Obstet+Gynecol+Rep 2016 ; 5 (ä): 38-47 Nephropedia Template TP {{tp|p=26949570|t=2016. Male Hormonal Contraception: Where Are We Now?|pdf=|usr=}}{{26949570}} gab.com Text Male Hormonal Contraception: Where Are We Now JO: Curr Obstet Gynecol Rep http://www.kidney.de/pget.php?&tw=1&pmid=26949570 #FOAvip Hormonal male contraception clinical trials began in the 1970s. The method is based on the use of exogenous testosterone alone or in combination with a progestin to suppress the endogenous production of testosterone and spermatogenesis. Studies using testosterone alone showed that the method was very effective with few adverse effects. Addition of a progestin increases the rate and extent of suppression of spermatogenesis. Common adverse effects include acne, injection site pain, mood change including depression, and changes in libido that are usually mild and rarely lead to discontinuation. Current development includes long-acting injectables and transdermal gels and novel androgens that may have both androgenic and progestational activities. Surveys showed that over 50 % of men will accept a new male method and female partners will trust their partner to take oral ?male pills.? Partnership between government, nongovernment agencies, academia, and industry may generate adequate interest and collaboration to develop and market the first male hormonal contraception. Twit Text FOAVip Male Hormonal Contraception: Where Are We Now ????Curr Obstet Gynecol Rep http://www.kidney.de/pget.php?&tw=1&pmid=26949570 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26949570 #FOAvip English Wikipedia <ref>{{Cite pmid|26949570}}</ref> Male Hormonal Contraception: Where Are We Now? #MMPMID26949570 Wang C; Festin MPR; Swerdloff RS Curr Obstet Gynecol Rep 2016[]; 5 (ä): 38-47 PMID26949570show ga Hormonal male contraception clinical trials began in the 1970s. The method is based on the use of exogenous testosterone alone or in combination with a progestin to suppress the endogenous production of testosterone and spermatogenesis. Studies using testosterone alone showed that the method was very effective with few adverse effects. Addition of a progestin increases the rate and extent of suppression of spermatogenesis. Common adverse effects include acne, injection site pain, mood change including depression, and changes in libido that are usually mild and rarely lead to discontinuation. Current development includes long-acting injectables and transdermal gels and novel androgens that may have both androgenic and progestational activities. Surveys showed that over 50 % of men will accept a new male method and female partners will trust their partner to take oral ?male pills.? Partnership between government, nongovernment agencies, academia, and industry may generate adequate interest and collaboration to develop and market the first male hormonal contraception. äMale Hormonal Contraception: Where Are We Now?(epmc).pdf DeepDyve Pubget Overpricing